Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | 80777-0112-96 | IM |
muscular tension; severe pains that move around the body; walking difficult; fever; This spontaneous case was reported by a non-health professional and describes the occurrence of MUSCLE TIGHTNESS (muscular tension), PAIN (severe pains that move around the body), GAIT DISTURBANCE (walking difficult) and PYREXIA (fever) in a 64-year-old male patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) (batch no. 80777-0112-96) for COVID-19 prophylaxis. No Medical History information was reported. On 24-Sep-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) .5 milliliter. On 28-Sep-2025, the patient experienced MUSCLE TIGHTNESS (muscular tension), PAIN (severe pains that move around the body), GAIT DISTURBANCE (walking difficult) and PYREXIA (fever). At the time of the report, MUSCLE TIGHTNESS (muscular tension), PAIN (severe pains that move around the body), GAIT DISTURBANCE (walking difficult) and PYREXIA (fever) had not resolved. The concomitant medication was not reported by the reporter. It was reported that the patient's side effects worsened four days after receiving the vaccine and did not go away. The patient had a fever, muscular tension, and severe pains that moved around the body and made walking difficult. It was unknown if the patient experienced any additional symptoms or events. The treatment medication was not reported by the reporter.